Optimal duration and dosage of BCG intravesical immunotherapy: A free final time optimal control approach (Q4644003): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
Removed claim: author (P16): Item:Q347092 |
||
| Property / author | |||
| Property / author: Mostafa Rachik / rank | |||
Revision as of 06:55, 13 February 2024
scientific article; zbMATH DE number 6876307
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal duration and dosage of BCG intravesical immunotherapy: A free final time optimal control approach |
scientific article; zbMATH DE number 6876307 |
Statements
Optimal duration and dosage of BCG intravesical immunotherapy: A free final time optimal control approach (English)
0 references
30 May 2018
0 references
BCG immunotherapy
0 references
bladder cancer
0 references
final gain function
0 references
free final time
0 references
maximum principle
0 references
optimal control
0 references
